Effect of Mavacamten on reducing sudden cardiac death risk in patients with Obstructive Hypertrophic Cardiomyopathy: an evaluation using the HCM-SCD Risk Score
Event:
EHRA 2025
Topic:
Diagnostic Methods
Session:
Poster session 2: arrhythmia mechanisms, device therapy, and ventricular arrhythmias